Application 074256
- Type
- ANDA
- Sponsor
- TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GEMFIBROZIL | GEMFIBROZIL | TABLET;ORAL | 600MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074256-001 | GEMFIBROZIL | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 1993-10-31 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 1993-10-31 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 1993-10-31 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | AB | 1993-10-31 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A074256-001 | GEMFIBROZIL | 600MG | TABLET / ORAL | 1993-10-31 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A074256-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A074256-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A074256-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A074256-001 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GEMFIBROZIL | GEMFIBROZIL | Bryant Ranch Prepack | 2cb2de4d-8261-46d8-ae63-c572fdc887d4 | 2024-08-26 | Warnings, Adverse reactions | GEMFIBROZIL GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | NuCare Pharmaceuticals, Inc. | 415ac7e0-ddc7-453e-e054-00144ff8d46c | 2024-08-14 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | Bryant Ranch Prepack | e3ef1638-4c2b-4f74-af31-52c081619963 | 2024-07-15 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | Rising Pharma Holdings, Inc. | 8f36abfa-dc52-4c99-8a4a-b0cb80c3249a | 2024-05-15 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | Aurobindo Pharma Limited | a68f430e-7c98-4bd9-8902-758706713996 | 2024-05-15 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | NorthStar Rx LLC | b5e33ee2-f766-41d6-8a4b-7b4f0e961bf4 | 2024-05-15 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | Aphena Pharma Solutions - Tennessee, LLC | 17529d33-f24a-1f3f-e063-6394a90ae374 | 2024-04-30 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | A-S Medication Solutions | 5738f713-d4b4-437c-b931-fb3b2c22f6d3 | 2023-12-18 | Boxed warning, Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | A-S Medication Solutions | 4907bbfa-27f4-4569-8957-9704f9c998a0 | 2023-12-18 | Boxed warning, Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | Zydus Lifesciences Limited | e6bc1a4f-2a4f-4fdf-8084-488ec8b8b7ab | 2023-12-15 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | Viona Pharmaceuticals Inc | 2fc2c8fe-6158-4e4d-9753-dc2be1b10f42 | 2023-12-15 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | Bryant Ranch Prepack | fe91d458-1877-4c2e-aa15-efd802e6741f | 2023-10-24 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| GEMFIBROZIL | GEMFIBROZIL | Bryant Ranch Prepack | 54c65a5d-2ff9-493a-90d9-2cff48d1a072 | 2023-09-15 | Warnings, Adverse reactions | GEMFIBROZIL GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | Cadila Pharmaceuticals Limited | 0b50849a-66b6-4e8f-9f45-5425a875d366 | 2022-12-27 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | NCS HealthCare of KY, LLC dba Vangard Labs | 394dfb45-cd3c-4e1e-8dd6-7e4867e90a03 | 2022-08-29 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | Proficient Rx LP | 7dbd38ab-7965-463f-9f8e-70efa8e071fb | 2022-04-01 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
| GEMFIBROZIL | GEMFIBROZIL | Aphena Pharma Solutions - Tennessee, LLC | 7379a1c1-d34f-4eb8-acb8-c5cbaea0f017 | 2021-11-01 | Warnings, Adverse reactions | GEMFIBROZIL GEMFIBROZIL |
| GEMFIBROZIL | GEMFIBROZIL | Camber Pharmaceuticals, Inc. | f6a2362a-21e1-442d-9f5d-9e600b5a2ea8 | 2021-08-26 | Warnings, Adverse reactions | GEMFIBROZIL GEMFIBROZIL |
| GEMFIBROZIL | GEMFIBROZIL | XLCare Pharmaceuticals, Inc. | 58c1f50b-9f84-42fe-b7dd-6eece286e28b | 2021-08-26 | Warnings, Adverse reactions | GEMFIBROZIL GEMFIBROZIL |
| Gemfibrozil | GEMFIBROZIL | Exelan Pharmaceuticals, Inc. | 5c09fe54-697e-4cd5-9a26-7c9c7fa9a864 | 2021-06-21 | Warnings, Adverse reactions | Gemfibrozil GEMFIBROZIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-0670 | Gemfibrozil | Gemfibrozil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-0670 | Gemfibrozil | Gemfibrozil | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0615-3559 | Gemfibrozil | Gemfibrozil | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | Current |
| 53808-0251 | Gemfibrozil | Gemfibrozil | State of Florida DOH Central Pharmacy | ANDA | Current |
| 67046-230 | Gemfibrozil | Gemfibrozil | Contract Pharmacy Services-PA | ANDA | Current |